Retatrutide metabolic outcomes in obesity study
study036
10.1016/S0140-6736(23)02026-2
The Lancet
phase 2 clinical trial
Retatrutide effects on weight and metabolic biomarkers evaluated.
Participants showed major reductions in body weight and improved metabolic markers.
retatrutide
fat-loss|metabolism
advanced-metabolic-stack
retatrutide-vs-tirzepatide
published